Abstract
How do “new” drug markets develop and operate? Which are the characteristics of synthetic drug suppliers? How are they organized, owned and managed? This article summarizes the outcomes of a cross-national study which investigated three urban synthetic drug markets at a different stage of development: Amsterdam, Barcelona and Turin. The study – the first of this type in Europe – outlines a composite picture which clearly indicates the presence of rather flexible and dynamic actors and a quasi “free” drug economy. Hence, the role played by more structured, mafia-type organizations, even in Italy, needs to be reconceived. The wide use of primary sources, altogether the adoption of qualitative interpretative tools, contributed to shed some light on a phenomenon which is still poorly investigated both at national and international levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
